期刊文献+

口腔鳞癌与正常黏膜中T细胞分化蛋白mRNA的表达 被引量:1

Investigation on mRNA expression of T-cell differentiation protein in oral squamous cell carcinoma and paired normal tissues
下载PDF
导出
摘要 目的:研究T细胞分化蛋白(T-cell differentiation protein,MAL)mRNA在口腔鳞状细胞癌(oral squamous cellcarcinoma,OSCC)及配对正常口腔黏膜组织中的表达及意义。方法:采用RT-PCR方法检测30例OSCC患者肿瘤组织及其配对的正常口腔黏膜中MAL mRNA的表达,所得数据采用SAS6.12软件包进行χ2检验和t检验。结果:RT-PCR检测表明,MAL mRNA在30例OSCC和配对正常黏膜的阳性率分别为36.7%(11/30)和86.7%(26/30)(P<0.001);总表达水平分别为1.20±0.18和2.96±0.36,OSCC中表达水平较正常黏膜中表达下调2.47倍(P<0.001);MALmRNA在OSCC中表达下调与患者的性别、肿瘤的临床分期、有无颈淋巴结转移等临床参数无关,但与病理分化程度显著相关。结论:在OSCC的癌变过程中,MAL mRNA表达下调,表明MAL基因可能是OSCC的一个靶基因;MAL在OSCC诊断中具有潜在的应用价值。 PURPOSE: To investigate mRNA expression of T-cell differentiation protein(MAL) gene in oral squamous cell carcinoma(OSCC) and paired normal tissues. METHODS: Differential MAL gene expression in 30 cases of paired normal and cancerous tissues were detected by reverse transcription-PCR (RT-PCR). The data were analyzed with SAS6.12 software package for Chi-square and t test. RESULTS: RT-PCR results demonstrated that the positive rate of MAL mRNA in 30 cancerous tissues and paired normal samples were 36.7% (11/30)and 40% 86.7% (26/30), respectively (P〈0.001); relative expression level of MAL mRNA in 30 cancerous tissues and paired normal samples were 1.20±0.18 and 2.96±0.36, respectively (P〈0.0001), totally down-regulated 2.47-fold. Additionally,the expression of MAL mRNA was significantly associated with the grade of tumor differentiation. No significant difference of MAL mRNA level was found between sexes, clinical stages, and cervical lymph node metastasis. CONCLUSIONS: MAL mRNA overexpression may play a significant role in OSCC carcinogenesis and may be a potential molecular marker of OSCC.
出处 《中国口腔颌面外科杂志》 CAS 2009年第3期241-243,共3页 China Journal of Oral and Maxillofacial Surgery
基金 国家自然科学基金重点项目(30330580) 上海市重点(优势)学科建设项目(Y0203)~~
关键词 口腔鳞状细胞癌 T细胞分化蛋白 RT-PCR Oral squamous cell carcinoma T-cell differentiation protein(MAL) RT-PCR
  • 相关文献

参考文献5

二级参考文献80

  • 1张壮,李宁毅,陈万涛,尚伟.口腔鳞癌中MMP-1、MMP-2、uPA的表达与肿瘤侵袭和转移的关系[J].实用口腔医学杂志,2006,22(4):469-473. 被引量:11
  • 2ZHANG Meng-zhen,QIAO Yu-huan,Jahn M Nesland,SUO Zhen-he.Expression of seprase in effusions from patients with epithelial ovarian carcinoma[J].Chinese Medical Journal,2007(8):663-668. 被引量:8
  • 3Saidi F, Sepehr A, Fahimi S, Farahvash MJ, Salehian P,Esmailzadeh A, Keshoofy M, Pirmoazen N, Yazdanbod M,Roshan MK. Oesophageal cancer among the Turkomans of northeast Iran. Br J Cancer 2000; 83:1249-1254.
  • 4Munoz N. Epidemiological aspects of oesophageal cancer. Endoscopy 1993; 23:609-612.
  • 5Lam AK. Molecular biology of oesophageal squamous cell carcinoma. Crit Rev Oncol Hematol 2000; 33:71-90.
  • 6Mandard AM, Hainaut P, Hollstein MI Genetic steps in the development of squamous cell carcinoma of the esophagus.Mutat Res 2000: 462:335-342.
  • 7Graber MW, Schweinfest CW, Reed CE, Papas TS, Baron PL.Isolation of differentially expressed genes in carcinoma of the esophagus. Ann Surg Oncol 1996; 3:192-197.
  • 8Xu Z, Wang MR, Xu X, Cai Y, Han YL, Wu KM, Wang J, Chen BS, Wang XQ, Wu M. Novel human esophagus-specific gene Clorfl0: cDNA cloning, gene structure, and frequent loss of expression in oesophageal cancer. Genomics 2000; 69:322-330.
  • 9Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpressionof Fra-1, Neogenin, Id-1 and CDC25B genes in ESCC. Clin Cancer Res 2001: 7:2213-2221.
  • 10Zhou J, Zhao LQ, Xiong MM, Wang XQ, Yang GR, Qiu ZL, Wu M, Liu ZH, Gene expression profiles at different stages of human esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9:9-15.

共引文献15

同被引文献14

  • 1Alonso MA, Weissman SM. cDNA cloning and sequence of MAL, a hydrophobic protein assisted with human T-cell differentiation [ J]. Proc Natl Acad Sci USA, 1957,84 (7) :1997.
  • 2Beder LB, Gunduz M, Hotomi M, et al. T-lymphocyte maturation-associated protein gene as a candidate metasta- sis suppressor for head and neck squamous cell carcinomas [J]. Cancer Sci, 2009, 100(5) :873.
  • 3Hatta M, Nagai H, Okino K, et al. Down-regulation ofmembers of glycolipid-enriched membrane raft gene fami- ly, MAL and BENE, in cervical squamous cell cancers [J]. J Obstet Gynaecol Res, 2004, 30(1): 53.
  • 4Lind GE, Ahlquist T, Kolberg M, et al. Hypermethylated MAL gene - a silent marker of early colon tumorigenesis [J]. TranslMes, 2008, 17(5) :6.
  • 5Cao W, Zhang ZY, Xu Q, et al. Epigenetie silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma[ J]. Mol Cancer, 2011, 9(1) :296.
  • 6Rancano C, Rubio T, Alonso MA. Alternative splicing of human T-cell-specific MAL mRNA and its correlation with the exon/intron organization of the gene [ J ]. Genomics, 1994, 21(2) :447.
  • 7Maqvar JP, Ebensperqer C, Schaeren-Wiemers N, et al. Myelin and lymphocyte protein(MAL/MVP17/VIP17) and plasmolipin are members of an extended gene family [ J ]. Gene, 1997, 159(2):268.
  • 8Millan J, Puertollano R, Fan L, et al. The MAL proteolip- id is a component of the detergent-insoluble membrane subdomains of human T-lymphocytes [ J ]. Biochem J, 1997, 321(1) :247.
  • 9Mimori K, Nishida K, Nakamura Y, et al. Loss of MAL expression in precancerous lesions of the esophagus [ J ]. Ann Surg Oncol, 2007, 14(5) :1670.
  • 10Zinovyeva MV, Monastyrskaya GS, Kopantzev EP, et al. Identification of some human genes oppositely regulated during esophageal squamous cell carcinoma formation and human embryonic esophagus devebpment[ J]. Dis Esoph- agus, 2010, 23(3) : 260.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部